
Mina Haghighatian
Examiner (ID: 16305, Phone: (571)272-0615 , Office: P/1616 )
| Most Active Art Unit | 1616 |
| Art Unit(s) | 1619, 1616 |
| Total Applications | 1588 |
| Issued Applications | 758 |
| Pending Applications | 188 |
| Abandoned Applications | 670 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16267167
[patent_doc_number] => 20200268654
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/864035
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16864035
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/864035 | NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF | Apr 29, 2020 | Abandoned |
Array
(
[id] => 16358429
[patent_doc_number] => 20200315180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => SOIL METABOLIZABLE CYANAMIDE PESTICIDE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/861322
[patent_app_country] => US
[patent_app_date] => 2020-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16861322
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/861322 | SOIL METABOLIZABLE CYANAMIDE PESTICIDE COMPOSITIONS | Apr 28, 2020 | Abandoned |
Array
(
[id] => 16204791
[patent_doc_number] => 20200237781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/843579
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20603
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843579
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843579 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | Apr 7, 2020 | Abandoned |
Array
(
[id] => 17554898
[patent_doc_number] => 11311555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => High-strength testosterone undecanoate compositions
[patent_app_type] => utility
[patent_app_number] => 16/843837
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20597
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843837
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843837 | High-strength testosterone undecanoate compositions | Apr 7, 2020 | Issued |
Array
(
[id] => 16504741
[patent_doc_number] => 20200383997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/843810
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843810 | High-strength testosterone undecanoate compositions | Apr 7, 2020 | Issued |
Array
(
[id] => 16548533
[patent_doc_number] => 10881671
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => High-strength testosterone undecanoate compositions
[patent_app_type] => utility
[patent_app_number] => 16/843721
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20580
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 237
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843721
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843721 | High-strength testosterone undecanoate compositions | Apr 7, 2020 | Issued |
Array
(
[id] => 16204792
[patent_doc_number] => 20200237782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/843759
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20582
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843759
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843759 | HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS | Apr 7, 2020 | Abandoned |
Array
(
[id] => 16375183
[patent_doc_number] => 20200324025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => COMPOSITIONS CONTAINING BONE MORPHOGENIC PROTEINS AND METHODS THEROF
[patent_app_type] => utility
[patent_app_number] => 16/839305
[patent_app_country] => US
[patent_app_date] => 2020-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839305
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/839305 | COMPOSITIONS CONTAINING BONE MORPHOGENIC PROTEINS AND METHODS THEROF | Apr 2, 2020 | Abandoned |
Array
(
[id] => 18003459
[patent_doc_number] => 20220362225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE
[patent_app_type] => utility
[patent_app_number] => 17/624433
[patent_app_country] => US
[patent_app_date] => 2020-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4713
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624433
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624433 | AEROSOL FORMULATION, CANISTER, AND INHALER CONTAINING THE FORMULATION, AND METHOD OF USE | Mar 17, 2020 | Pending |
Array
(
[id] => 16174734
[patent_doc_number] => 20200221702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => POST-EMERGENCE HERBICIDE
[patent_app_type] => utility
[patent_app_number] => 16/820436
[patent_app_country] => US
[patent_app_date] => 2020-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29294
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16820436
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/820436 | POST-EMERGENCE HERBICIDE | Mar 15, 2020 | Abandoned |
Array
(
[id] => 17088562
[patent_doc_number] => 11116730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Transdermal formulation for the treatment of pain and/or inflammation
[patent_app_type] => utility
[patent_app_number] => 16/818755
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10349
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818755
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/818755 | Transdermal formulation for the treatment of pain and/or inflammation | Mar 12, 2020 | Issued |
Array
(
[id] => 20200333
[patent_doc_number] => 12403098
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-02
[patent_title] => Pharmaceutical dosage form for application to mucous membranes and methods for producing same
[patent_app_type] => utility
[patent_app_number] => 17/439385
[patent_app_country] => US
[patent_app_date] => 2020-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 39
[patent_no_of_words] => 20635
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439385
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/439385 | Pharmaceutical dosage form for application to mucous membranes and methods for producing same | Mar 12, 2020 | Issued |
Array
(
[id] => 16086823
[patent_doc_number] => 20200197398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => NETARSUDIL AND LOW-DOSE BRIMONIDINE COMBINATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/810095
[patent_app_country] => US
[patent_app_date] => 2020-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16810095
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/810095 | NETARSUDIL AND LOW-DOSE BRIMONIDINE COMBINATION AND USES THEREOF | Mar 4, 2020 | Pending |
Array
(
[id] => 17377024
[patent_doc_number] => 11235013
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods
[patent_app_type] => utility
[patent_app_number] => 16/807256
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 12071
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807256
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807256 | Cannabinoid, menthol and caffeine dissolvable film compositions, devices and methods | Mar 2, 2020 | Issued |
Array
(
[id] => 17362602
[patent_doc_number] => 11229610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-25
[patent_title] => Cannabinoid and menthol gel compositions, patches and methods
[patent_app_type] => utility
[patent_app_number] => 16/807229
[patent_app_country] => US
[patent_app_date] => 2020-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 11518
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16807229
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/807229 | Cannabinoid and menthol gel compositions, patches and methods | Mar 2, 2020 | Issued |
Array
(
[id] => 16405353
[patent_doc_number] => 10813889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-27
[patent_title] => Cannabinoid and menthol compositions and methods
[patent_app_type] => utility
[patent_app_number] => 16/806476
[patent_app_country] => US
[patent_app_date] => 2020-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 13518
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16806476
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/806476 | Cannabinoid and menthol compositions and methods | Mar 1, 2020 | Issued |
Array
(
[id] => 16009073
[patent_doc_number] => 20200179379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => INTRANASAL DHE FOR THE TREATMENT OF HEADACHE
[patent_app_type] => utility
[patent_app_number] => 16/791431
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791431
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791431 | INTRANASAL DHE FOR THE TREATMENT OF HEADACHE | Feb 13, 2020 | Abandoned |
Array
(
[id] => 16326660
[patent_doc_number] => 20200297625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
[patent_app_type] => utility
[patent_app_number] => 16/773656
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12957
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773656
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773656 | DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS | Jan 26, 2020 | Abandoned |
Array
(
[id] => 17648416
[patent_doc_number] => 11351115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Inhalable particles
[patent_app_type] => utility
[patent_app_number] => 16/715332
[patent_app_country] => US
[patent_app_date] => 2019-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 8685
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715332
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/715332 | Inhalable particles | Dec 15, 2019 | Issued |
Array
(
[id] => 17355248
[patent_doc_number] => 20220016044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => Oral Thin Films
[patent_app_type] => utility
[patent_app_number] => 17/311153
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17311153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/311153 | Oral Thin Films | Dec 5, 2019 | Pending |